OkaiDx Pancreatic Cancer Detection Blood Test

The OkaiDx Pancreatic Cancer Detection Blood Test is a laboratory-developed test (LDT) performed at EG BioMed's CLIA/CAP-certified laboratory in the Washington State.

• Simple blood draw analyzed with advanced cfDNA methylation technology
• Intended for early health screening purposes
• Developed through international scientific collaboration and presented at leading global conferences
• Conduction in regulated clinical laboratory under strict quality standards

Special Promotion - Save over 40%! Original $500, now only $289.

Please note:
This test requires physician authorization. The required physician consultation and order review are included in the test price and are covered as part of your purchase. All orders are reviewed by a licensed physician. Testing will proceed only after physician approval.

Blood Collection Process:
If your order is approved:
1. A Blood Collection Kit will be shipped to you.
2. You will be asked to schedule an in-home blood draw service.
3. The in-home blood draw service fee is the responsibility of the patient and is not included in the test price.
If you cancel your order after the Blood Collection Kit has been shipped, a $200 kit fee will be deducted from your refund. The remaining balance, if any, will be refunded to your original method of payment.

Disclaimer: This test is offered as laboratory-developed tests (LDTs) by EG BioMed US Inc. Testing is performed exclusively in our CLIA-certified and CAP-accredited laboratory, where the analytical performance of the test has been fully validated to ensure the reliable result. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) and is currently available as LDTs.